Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Japanese lab presents new quinazoline chymase inhibitors

April 4, 2000

Nortran begins phase II trial of CP1 for chronic idiopathic cough

March 31, 2000

Merck & Co. confirms study results of Singulair as allergic rhinitis treatment

March 29, 2000

ACS news: Texas Biotechnology presents synthesis, activity of new VLA-4 antagonist

March 28, 2000

Schering-Plough's new H3 receptor antagonists particularly useful for allergy

March 27, 2000

Ebelsen studied in models of lung injury, lung inflammation

March 23, 2000

Baxter and AlphaOne to codevelop rAAT treatment of hereditary emphysema

March 23, 2000

Shionogi's TxA2 receptor antagonist inactive in model of silica-induced lung fibrosis

March 22, 2000

Drug notification issued for Pulmozyme due to packaging defect

March 22, 2000

Alliance makes progress in phase II/III LiquiVent trial

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...